Concord Biotech Limited (BOM:543960)
India · Delayed Price · Currency is INR 1,046.80
-20.60 (-1.93%)
At close: Apr 21, 2026
Concord Biotech Market Cap
Concord Biotech has a market cap or net worth of 109.19 billion as of April 22, 2026. Its market cap has decreased by -36.89% in one year.
Market Cap
109.19B
Enterprise Value
105.88B
Revenue
11.59B
Ranking
n/a
PE Ratio
34.94
Stock Price
1,046.80
Market Cap Chart
Since August 18, 2023, Concord Biotech's market cap has increased from 98.63B to 109.19B, an increase of 10.70%. That is a compound annual growth rate of 3.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 20, 2026 | 111.56B | -20.75% |
| Dec 31, 2025 | 140.77B | -39.13% |
| Dec 31, 2024 | 231.28B | 50.21% |
| Dec 29, 2023 | 153.97B | 56.11% |
| Aug 18, 2023 | 98.63B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 320.69B |
| AstraZeneca Pharma India | 213.00B |
| Granules India | 164.48B |
| Rubicon Research | 152.81B |
| Jubilant Pharmova | 143.25B |
| Caplin Point Laboratories | 133.34B |
| CORONA Remedies | 103.87B |
| Viyash Scientific | 91.18B |